BHIVA/BASHH guidelines on the use of HIV pre–exposure prophylaxis (PrEP) 2018

Michael Brady, Alison Rodger, David Asboe, Valentina Cambiano, Dan Clutterbuck, Monica Desai, Nigel Field, Justin Harbottle, Zahra Jamal, Sheena McCormack,

HIV Medicine · 2019 · 94 citations · 106 references

DOIFull text

Open access

Concepts

Abstract

We aim to provide evidence-based guidance on best clinical practice in the provision, monitoring and support of pre-exposure prophylaxis (PrEP) for the prevention of HIV acquisition. The guidelines include:
\n(i) Guidance on risk assessment prior to PrEP;
\n(ii) Baseline assessment;
\n(iii) Dosing schedules;
\n(iv) Monitoring;
\n(v) Supporting adherence;
\n(vi) Buying generic PrEP; and
\n(vii) Cost-effectiveness.
\nThe guidelines are aimed at clinical professionals directly involved in, and responsible for, HIV prevention, and at community advocates and organisations responsible for supporting HIV prevention strategies in those at risk of HIV acquisition. A detailed review of the evidence base is included in Section 4. Sections 5 to 7 are intended to offer practical guidance in risk assessment, starting PrEP, ongoing management while on PrEP and stopping PrEP.

References

106